Stryker Corporation SYK
announced today that its orthopaedic division has received notice that the
U.S. Food and Drug Administration (FDA) has reviewed the voluntary recall of
its ShapeMatch Cutting Guides and that it will be classified as a Class I
recall.
ShapeMatch Cutting Guides are intended to be used as patient specific surgical
instrumentation to assist in the positioning of total knee replacement
components intraoperatively and in guiding the marking of bone before cutting.
In November 2012, Stryker Orthopaedics instructed all U.S. registered
ShapeMatch surgeons to discontinue use and ordering of ShapeMatch Cutting
Guides and in January 2013 voluntarily recalled the product. These actions
were due to the potential that ShapeMatch Cutting Guides may not have been
manufactured in accordance with surgeon preoperative planning parameters or
may have been manufactured outside of the planning ranges specified in the
510(k) clearance. This issue was identified through standard post-market
surveillance of product complaints. A Product Notification was issued to
surgeons and hospital risk managers which described the known hazards and
harms potentially associated with the use of the affected products, which
could result in a knee not functioning properly.
As stated in the January 2013 Product Notification, Stryker recommended that
patient follow-up beyond the routine standard of care was not necessary.
Patients who have had knee replacement surgery in which ShapeMatch Cutting
Guides were used and who feel their knee may not be functioning properly
should contact their surgeon. Patients may also contact Stryker at
1-888-STRYKER with questions regarding this Class I recall Monday - Friday,
8am-8pm EST.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: News
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in